دورية أكاديمية
A case report of LAI two injection start in a 16-year-old adolescent with severe manic episode and comorbid cannabinoid use disorder.
العنوان: | A case report of LAI two injection start in a 16-year-old adolescent with severe manic episode and comorbid cannabinoid use disorder. |
---|---|
المؤلفون: | Orsolini L; Unit of Clinical Psychiatry, Department of Neurosciences/DIMSC, School of Medicine and Surgery, Polytechnic University of Marche, Ancona, Italy. Electronic address: l.orsolini@staff.univpm.it., Biagiotti SP; Unit of Clinical Psychiatry, Department of Neurosciences/DIMSC, School of Medicine and Surgery, Polytechnic University of Marche, Ancona, Italy., Martino LM; Unit of Clinical Psychiatry, Department of Neurosciences/DIMSC, School of Medicine and Surgery, Polytechnic University of Marche, Ancona, Italy., Volpe U; Unit of Clinical Psychiatry, Department of Neurosciences/DIMSC, School of Medicine and Surgery, Polytechnic University of Marche, Ancona, Italy. |
المصدر: | Asian journal of psychiatry [Asian J Psychiatr] 2024 Apr; Vol. 94, pp. 103992. Date of Electronic Publication: 2024 Mar 04. |
نوع المنشور: | Case Reports; Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101517820 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1876-2026 (Electronic) Linking ISSN: 18762018 NLM ISO Abbreviation: Asian J Psychiatr Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: [Amsterdam] : Elsevier |
مواضيع طبية MeSH: | Antipsychotic Agents*/therapeutic use , Bipolar Disorder*/drug therapy, Male ; Adolescent ; Humans ; Aripiprazole ; Mania/drug therapy ; Delayed-Action Preparations/therapeutic use |
مستخلص: | There is a lack of randomized clinical trials and few studies regarding long-acting injectable antipsychotics (LAIs) in adolescents. Non-adherence, aggressiveness, comorbid substance use disorder and lack of insight may represent the main reasons for starting LAIs. Hereby we describe a 16-year-old male adolescent subject with bipolar type I disorder and comorbid cannabinoid use disorder, successfully treated with two-injection start regimen of LAI aripiprazole. Two-injection start regime of aripiprazole could represent an effective and safe therapeutic option for adolescents with early onset bipolar disorder. Competing Interests: Declaration of Competing Interest All authors do not have any competing interests to disclose. (Copyright © 2024 Elsevier B.V. All rights reserved.) |
فهرسة مساهمة: | Keywords: Adolescent; Aripiprazole; Bipolar Disorder; LAI; Long-acting injectable aripiprazole; Two-injection start aripiprazole |
المشرفين على المادة: | 82VFR53I78 (Aripiprazole) 0 (Delayed-Action Preparations) 0 (Antipsychotic Agents) |
تواريخ الأحداث: | Date Created: 20240310 Date Completed: 20240401 Latest Revision: 20240401 |
رمز التحديث: | 20240401 |
DOI: | 10.1016/j.ajp.2024.103992 |
PMID: | 38461611 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1876-2026 |
---|---|
DOI: | 10.1016/j.ajp.2024.103992 |